WO2008061447A1 - A medicine for treating eczema and process of ointment thereof - Google Patents

A medicine for treating eczema and process of ointment thereof Download PDF

Info

Publication number
WO2008061447A1
WO2008061447A1 PCT/CN2007/003272 CN2007003272W WO2008061447A1 WO 2008061447 A1 WO2008061447 A1 WO 2008061447A1 CN 2007003272 W CN2007003272 W CN 2007003272W WO 2008061447 A1 WO2008061447 A1 WO 2008061447A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
add
skin
filter
filtrate
Prior art date
Application number
PCT/CN2007/003272
Other languages
French (fr)
Chinese (zh)
Inventor
Jinghua Chen
Original Assignee
Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd filed Critical Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd
Publication of WO2008061447A1 publication Critical patent/WO2008061447A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Definitions

  • the invention relates to a traditional Chinese medicine for treating eczema and a preparation method thereof.
  • Eczema is a common inflammatory skin disease of the skin, which is named after the rash lesion has a tendency to exude moisture. The course of the disease is protracted and easy to relapse.
  • the clinical symptoms of eczema vary widely. According to the different manifestations of skin lesions during the onset, they are classified into acute, subacute and chronic types.
  • the damage of acute eczema is pleomorphic, initially erythema, consciously burning and itching. Following the presence of scattered or dense papules or small blisters on the erythema, after scratching or rubbing, it smashes to form a smashed, oozing surface.
  • Chronic eczema is caused by acute and subacute recurrent episodes, or chronic inflammation at the beginning. It is often characterized by a long-term unhealed condition in a certain part, which is characterized by thickening of the skin and deepening of the skin. Infiltration, pigmentation, etc. The main symptoms are intense itching.
  • eczema The etiology and pathogenesis of eczema is quite complex and involves many factors, both internal and external. It is a delayed type of allergic reaction that occurs in the skin. This disease often occurs in individuals with allergic qualities.
  • An individual with this quality allergic substances in and out of the body, such as protein in food, especially fish, shrimp, eggs and milk, as well as chemicals, plants, animal leather and feathers, parasites in the intestines, infections
  • the effect of the stove is prone to allergic reactions than normal people.
  • Some even physical stimuli such as sunlight, wind, and cold can induce eczema.
  • the occurrence of eczema may sometimes have a certain relationship with neurological dysfunction, endocrine disorders, dyspepsia, intestinal diseases, metabolic abnormalities, etc.
  • eczema the onset of eczema is caused by the interaction of various factors.
  • Western medicine is more than oral antihistamine treatment, such as diphenhydramine, phenacetin, chlorpheniramine, cyproheptadine, etc.
  • the external dosage form depends on the clinical skin lesions, such as redness and swelling.
  • Exudation should be selected as cold and wet compress, erythema and papules can be used as lotion, emulsion, mud, oil, etc.; blisters, smashed need to use Oil; It is an ointment for scaling and crusting; if the moss is changed, choose a mud, ointment, emulsion, filming agent, tincture and hard plaster.
  • Zhongcheng has medicines such as stomach sputum pills and dehumidification pills, and there are various lotions for external use.
  • the object of the present invention is to provide a traditional Chinese medicine preparation for treating eczema, and enrich the treasure house of Chinese medicine.
  • Another object of the present invention is to provide a method for preparing a traditional Chinese medicine ointment for treating eczema for the convenience of a patient.
  • the traditional Chinese medicine formula for treating eczema of the present invention is that the medicine is an agent made of the following raw materials by weight ratio:
  • a preferred embodiment of the medicament for treating genital warts of the present invention an agent made from the following raw materials by weight:
  • the main ingredients of Sophora flavescens are more than 10 kinds of alkaloids such as matrine and alkali, which are characterized by sexual cold and bitter taste.
  • the main functions are heat-clearing diuretic and dampness.
  • the main components of borneol are L-Dragon's brain and a small amount of eucalyptus oil, L-camphor and sesquiterpene alcohol. Its characteristics are slightly cold, taste hard, and aromatic sputum. The main effect is to reduce swelling and pain, and to clear eyesight.
  • peony bark The main ingredients of peony bark are peony phenol, peony peony, volatile oil, etc. Its characteristics are slightly cold, bitter and spicy, and its main effect is clearing heat and cooling blood, promoting blood circulation and removing blood stasis.
  • the main ingredients of white fresh skin are white fresh alkali, alkaloids, and jalapeno. Their characteristics are sexual cold and bitter taste.
  • the main functions are detoxification, dehumidification, hurricane and insecticide.
  • the medicament of the invention has the effects of clearing heat and dampness, detoxifying and relieving itching, and is mainly used for damp-heat injection type, and the symptoms such as severe itching, thickening of the skin, pigmentation and the like.
  • step 3 Add 6 times the amount of water to the dregs obtained in step 2), decoct for 1 hour, filter, and combine the filtrates, and use them separately;
  • Step 4) taking 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium decyl sulfate, 370 ml of water to prepare a matrix, and obtaining paeonol with step 2), Step 4)
  • a drug ointment and 10 g of borneol are uniformly mixed to obtain about 1000 g of a drug ointment for treating eczema.
  • the invention has the advantages of simple use, small side effects, and clinically proven that the total effective rate is over 80%.
  • the medicament for treating eczema of the present invention is a medicament prepared from the following raw materials by weight ratio: Sophora flavescens 150 ⁇ 600 white fresh skin 100 ⁇ 300 Mudanpi 150 ⁇ 600 borneol 5 ⁇ 25
  • the preferred embodiment of the present invention for treating eczema is prepared according to the following raw materials by weight ratio: bitter ginseng 300 white fresh skin 200 peony bark 300 ice piece 10
  • the pharmaceutical dosage form is any of the pharmaceutically acceptable dosage forms, and the object of the invention can be achieved.
  • the preparation method of the ointment for treating eczema according to the present invention is particularly important because the medicine is mainly treated, and the antibacterial and anti-inflammatory effect is particularly important.
  • the antibacterial and anti-inflammatory medicinal ingredients are mainly preserved.
  • the main active ingredients of Sophora flavescens are alkaloids such as matrine and oxymatrine, mainly in the peony bark.
  • the water extraction process of Sophora flavescens is preferably determined as follows:
  • A.2. Orthogonal test According to the results of pre-test, choose three factors: solvent dosage, boiling time and boiling time. The process is preferred at three levels of each factor.
  • the factor level table is shown in Table-1.
  • A.2.1.1 Determination of matrine content Weigh 15g of Sophora flavescens coarse powder, 10g of white fresh skin, test according to the orthogonal table, filter, the filtrate is fixed to the corresponding volumetric flask, let cool, add water separately To the scale, shake well and serve as the test solution.
  • the dried reference constant dry matrine reference substance 2.80mg, dissolved in methanol, transferred to a 5ml volumetric flask, as a reference solution.
  • A.2.1.1 Determination of the creaming rate According to the orthogonal test, the filtrate is set to 1000 ml volumetric flask, add water to the mark, shake well, take 50ml, place the constant weight of the evaporating dish, water bath Evaporate to dryness, transfer to an oven, bake at 80 ° C to dry paste, and weigh.
  • the extraction number C is the main influencing factor, and C3>C2>C1, so the C3 level is selected;
  • the B factor is also the main factor, but combined with the results of the range analysis, B2 and B3 levels. There is not much difference, but there is a big difference with B1. Therefore, the B3 level can be selected.
  • the A factor the A2 and A3 levels are not much different, but there is a big difference with A1. Therefore, the A3 level can be selected.
  • the preferred process conditions are A3B3C3; B and C are significant factors in terms of the creaming rate, but 3 is the most ambiguous in the orthogonal table, namely A1B3C3, so the comprehensive consideration of A3B3C3 is considered as the best condition, that is, the medicine is added to 10 Double the amount of water, decoct 3 times, 2 hours each time.
  • A.2.3 Verification test According to the conditions determined by the orthogonal test, the operation is performed in parallel twice, and the verification test is carried out with the matrine and the ointment rate as indicators. The comparison test is carried out according to the optimal process A3B3C3 in the process optimization. The following table. It indicates that the preferred process is better than the reference process, and the determined process is a better process. Table -5 Results of the verification process of the extraction process of Sophora flavescens water:
  • step 3 Add 6 times of water to the obtained dregs of step 2), decoct for 1 hour, filter, and combine the filtrates for use;
  • the selection process of a peony skin medicinal material is preferably determined as follows:
  • the extraction experiment of paeonol in al medicinal materials is as follows - a.1.1 peony bark is mainly composed of paeonol, which is proposed as much as possible without excessive dissolution of polymer viscous material, which makes filtration difficult.
  • the peony skin material is coarsely pulverized to make it "fine but not powder", which can increase the surface area to facilitate the dissolution of the components, and does not cause the gelatinization to affect the dissolution and filtration of the components.
  • three factors including the water addition ratio, the pretreatment of the medicinal material and the salt addition amount, were designed for comparative tests.
  • A.1.2 Pre-test We carried out a pre-test for extracting paeonol, weighed 20g of peony bark, placed it in a 500ml round bottom flask, extracted by steaming, collected different volumes of distillate, refrigerated and crystallized, filtered, and filtrate added. Distilled with 5% sodium chloride, collected 3 times distillate, recrystallized and crystallized, filtered, and the filtrate was extracted with diethyl ether three times, 50 ml each time, and the ether was evaporated. The crystals were combined, dried at 40 ° C for 1 hour, and weighed. As follows: Extraction of paeonol pre-test results:
  • A.1.3.1 Factor level table According to the results of the pre-test, the factor level table of the double-rectification orthogonal test is designed, see Table -7.
  • C is the main factor, should choose the best level C2
  • A, B are secondary factors, combined with economic and provincial time preference, should choose A 1 and B1, but considering the slow discharge of large production equipment, the distillation time should be extended
  • A2 can be selected, because the temperature immersion can speed up the distillation time, so the extraction process of paeonol is preferably A2B3C2, that is, the medicinal material is added with 20 times of water, first immersed for 1 hour, and then distilled and extracted, and Secondary distillation plus 5 ⁇ /. Sodium chloride.
  • A.1.3.3 Verification test We carried out the verification test of extracting paeonol. According to the proportion of prescription, accurately weigh 100g of peony bark, operate 2 times according to the experimental conditions, add 20 times of water, extract the paeonol by distillation. Phenol, and a comparative test of No. 9 experiment A3B3C2, which is intuitively analyzed in the orthogonal table of the process, was carried out. The results are shown in the table below, indicating that the preferred process is comparable to that obtained by A3B3C2, and the determined process is a better process.
  • the dregs still contain water-soluble components. Since it has been distilled for a long time, it can be boiled for a short time. Because the first decoction has been fully swelled, the second frying is added. The amount of liquid was determined to be 6 times. We used the yield of ethanol extract as an indicator to investigate the number of decoctions of the drug.
  • A.2.1 Test method Weigh 100g of peony bark, and test according to the preferred conditions. After the extraction of paeonol, filter it, collect the drug solution as sample 1, add 6 times of water to the dregs, and fry 2 , every time for 1 hour, filter, collect the liquid, get sample 2, sample 3, 3 samples are separately concentrated to 100ml (60'C), add an equal volume of ethanol, so that the alcohol-soluble components are dissolved, refrigerated for 24 hours, Filtration, filtrate Concentrate to dryness, bake in an oven to constant weight (105 e C), weigh, and subtract the weight of the evaporating dish to obtain the amount of ethanol extract.
  • A.2.3 Verification test We carried out the verification test of the number of decoction of the dregs after extracting paeonol. According to the proportion of prescription, we accurately weighed lKg of peony bark and operated according to the experimental conditions. The results are shown in the table below, indicating that the medicinal material is extracted. After the phenol, add 6 times the amount of water to cook for 1 hour.
  • the proportion of the third decocted alcohol extract (%) 4.92 4.83 b, the decoction alcohol precipitation process is preferred: according to the extraction process preferred results, water decoction to achieve a paste of about 40%, after the alcohol precipitation, the paste rate can be greatly reduced.
  • the alcohol precipitation can remove polymer impurities such as pectin and starch to achieve further purification. Therefore, the aqueous extract can be concentrated and then refined by an alcohol precipitation process. In the experiment, the alcohol precipitation was compared to make the alcohol content up to 40%, 50%, 60%, and 70%.
  • Test method According to the prescription ratio, weighed 75g of Sophora flavescens and 50g of white fresh skin, a total of 175g, coarsely crushed, According to the optimal conditions obtained by the process, the filtrate is combined; 50 g of peony bark is taken, extracted by distillation, and the filtrate is combined, and then combined with the above solution, and further concentrated to a relative density of 1.06 (60 ° C), about 175 ml. .
  • the dry paste powder was transferred to a 100 ml round bottom flask, refluxed with 50 ml of absolute ethanol for 1 hour, filtered, and the filtrate was steamed to about 5 ml in a water bath, transferred to a 5 ml volumetric flask, and anhydrous ethanol was added to the mark to measure
  • Table-13 The content of paeoniflorin, the results are shown in Table-13:
  • the water extract is concentrated to a relative density of 1.06-1.10 (60 e C), and ethanol precipitation is preferred.
  • the relative density of the liquid is less than 1.06, the concentration of the liquid is relatively thin, and the amount of alcohol is large; when the relative density of the liquid is higher than 1.10, the concentration of the liquid is large, and the liquid is not easily dispersed even when the alcohol is sedimented.
  • the water extract is concentrated by three-effect decompression, and the efficiency is low.
  • Step 4) taking 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium lauryl sulfate, 370 ml of water to prepare a matrix, and step 2) to obtain paeonol.
  • Step 4) After the drug thick cream and the borneol 10g are uniformly mixed, a pharmaceutical ointment for treating eczema can be obtained by about 1000 g.
  • the base is prepared according to the following matrix formulation, and then mixed with the drug cream by a grinding method. It is preferred to use skin irritation and heat resistance and cold resistance tests as indicators.
  • Hardness is viscous and resistant to 55. C resistant to -15. C (2) Softness is easy to apply and is not resistant to 45'C.
  • the matrix (4) is more suitable. Namely, 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium decyl sulfate, and 450 ml of water. ,

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A medicine for treating eczema and process of ointment thereof. The medicine is prepared by using 150-600 parts by weight of radix sophora flavescens Ait., 100-300 parts by weight of cortex dictamnus dasycarpus Turcz., 150-600 parts by weight of cortex paeonia suffruticosa Andr., and 5-25 parts by weight of borneol as raw materials.

Description

确认 一种治疗湿疹的药物及其软膏的制备方法 所属技术领域  Confirmation method for preparing eczema and preparation method thereof
本发明涉及一种用于治疗湿疹的中药及其软膏的制备方法。  The invention relates to a traditional Chinese medicine for treating eczema and a preparation method thereof.
背景技术 Background technique
湿疹是一种常见的皮肤炎性皮肤病, 以皮疹损害处具有渗出潮湿倾向而 故名。 该病病程迁延难愈、 易复发。 湿疹临床症状变化多端, 根据发病过程 中的皮损表现不同, 分为急性、 亚急性和慢性三种类型。 急性湿疹的损害多 形性, 初期为红斑, 自觉灼热、 瘙痒。 继之在红斑上出现散在或密集的丘疹 或小水疱, 搔抓或摩擦之后, 搔破而形成糜烂、 渗液面。 日久或治疗后急性 炎症减轻、 皮损干燥、 结痂、 鳞屑, 而进入亚急性期。 慢性湿疹是由急性、 亚急性反复发作不愈演变而来, 或是开始时即呈现慢性炎症, 常以局限于某 一相同部位经久不愈为特点, 表现为皮肤逐渐增厚, 皮紋加深、 浸润, 色素 沉着等。 主要自觉症状是剧烈瘙痒。  Eczema is a common inflammatory skin disease of the skin, which is named after the rash lesion has a tendency to exude moisture. The course of the disease is protracted and easy to relapse. The clinical symptoms of eczema vary widely. According to the different manifestations of skin lesions during the onset, they are classified into acute, subacute and chronic types. The damage of acute eczema is pleomorphic, initially erythema, consciously burning and itching. Following the presence of scattered or dense papules or small blisters on the erythema, after scratching or rubbing, it smashes to form a smashed, oozing surface. After a long time or after treatment, the acute inflammation is relieved, the skin lesions are dry, crusted, and scaly, and enter the subacute phase. Chronic eczema is caused by acute and subacute recurrent episodes, or chronic inflammation at the beginning. It is often characterized by a long-term unhealed condition in a certain part, which is characterized by thickening of the skin and deepening of the skin. Infiltration, pigmentation, etc. The main symptoms are intense itching.
湿疹的病因及发病机制相当复杂, 涉及体内、 外多种因素。 是发生在皮 肤的一种迟发型变态反应。 本病常发生于具有过敏素质的个体。 凡有此素质 的人, 对体内外各种致敏物质, 如食物中蛋白质, 尤其是鱼、 虾、 蛋类及牛 乳, 还有化学物品、 植物、 动物皮革及羽毛、 肠道中寄生虫, 感染灶等的作 用较正常人容易发生过敏反应。 有的甚至连日光、 风热、 寒冷等物理刺激皆 可诱发湿疹。 此外, 湿疹的发生, 有时还可能与神经功能障碍、 内分泌失调、 消化不良、 肠道疾病、 新陈代谢异常等有一定的关系, 总而言之, 湿疹的发 病是诸种因素相互作用所致。 ' 目前对湿疹的治疗, 西医多釆以内服抗组胺药物治疗为多, 如苯海拉明、 非那根、 扑尔敏、 赛庚啶等, 既可单用或联用, 还可与镇静药、 维生素 C等 合用。 外用药剂型依据临床皮损表现而定, 如红肿明显, 渗出多者应选溶液 冷湿敷, 红斑、 丘疹时可用洗剂、 乳剂、 泥膏、 油剂等; 呈水疱、 糜烂者需 用油剂; 表现为鳞屑、 结痂者用软膏; 若苔藓样变者多择泥膏、 软膏、 乳剂、 涂膜剂、 酊剂及硬膏等。 The etiology and pathogenesis of eczema is quite complex and involves many factors, both internal and external. It is a delayed type of allergic reaction that occurs in the skin. This disease often occurs in individuals with allergic qualities. Anyone with this quality, allergic substances in and out of the body, such as protein in food, especially fish, shrimp, eggs and milk, as well as chemicals, plants, animal leather and feathers, parasites in the intestines, infections The effect of the stove is prone to allergic reactions than normal people. Some even physical stimuli such as sunlight, wind, and cold can induce eczema. In addition, the occurrence of eczema may sometimes have a certain relationship with neurological dysfunction, endocrine disorders, dyspepsia, intestinal diseases, metabolic abnormalities, etc. In summary, the onset of eczema is caused by the interaction of various factors. ' At present, the treatment of eczema, Western medicine is more than oral antihistamine treatment, such as diphenhydramine, phenacetin, chlorpheniramine, cyproheptadine, etc., can be used alone or in combination, but also with Sedatives, vitamin C, etc. Use together. The external dosage form depends on the clinical skin lesions, such as redness and swelling. Exudation should be selected as cold and wet compress, erythema and papules can be used as lotion, emulsion, mud, oil, etc.; blisters, smashed need to use Oil; It is an ointment for scaling and crusting; if the moss is changed, choose a mud, ointment, emulsion, filming agent, tincture and hard plaster.
对湿疹的治疗中药有口服药和外用药, 中成有药胃苓丸、 除湿丸等, 外 用药有各种洗剂等。  There are oral and topical medicines for the treatment of eczema. Zhongcheng has medicines such as stomach sputum pills and dehumidification pills, and there are various lotions for external use.
随着祖国中医药宝库的研究和开发, 人们保健意识的提高, 祖国中药在 治疗疾病时带来的副作用小已被人们所接受, 采用天然中药用于人类疾病的 治疗已成为首选。  With the research and development of the treasure house of Chinese medicine in the motherland, people's health awareness has improved, and the side effects of traditional Chinese medicine in the treatment of diseases have been accepted. The use of natural Chinese medicine for the treatment of human diseases has become the first choice.
发明目的 Purpose of the invention
本发明的目的是, 提供一种治疗湿疹的外用中药制剂, 丰富我国中医药 宝库。  The object of the present invention is to provide a traditional Chinese medicine preparation for treating eczema, and enrich the treasure house of Chinese medicine.
本发明的另一发明目的是, 为方便患者使用, 提供一种治疗湿疹的中药 软膏制剂的制备方法。  Another object of the present invention is to provide a method for preparing a traditional Chinese medicine ointment for treating eczema for the convenience of a patient.
本发明治疗湿疹的中药配方是, 该药物是由下述重量份配比的原料制成 的药剂:  The traditional Chinese medicine formula for treating eczema of the present invention is that the medicine is an agent made of the following raw materials by weight ratio:
苦 参 150~600 白鲜皮 100~300 牡丹皮 150~600 冰 片 5~25 Kushen 150~600 white fresh skin 100~300 peony skin 150~600 ice sheet 5~25
本发明治疗湿瘆的药物的最佳实施例, 由下述重量份配比的原料制成的 药剂:  A preferred embodiment of the medicament for treating genital warts of the present invention, an agent made from the following raw materials by weight:
苦 参 300 白鲜皮 200 牡丹皮 300 冰 片 10 Kushen 300 white fresh skin 200 peony skin 300 ice sheet 10
苦参的主要成份是苦参碱及氧化碱等 10多种生物碱, 其特性为性寒、 味 苦,主要功效是清热利尿、 燥湿杀虫。 冰片的主要成份是左旋龙脑和少量的桉油精、左旋樟脑和倍半萜醇,其特 性为性微寒, 味辛苦、 芳香开窍, 主要功效是消肿止痛, 去翳明目。 The main ingredients of Sophora flavescens are more than 10 kinds of alkaloids such as matrine and alkali, which are characterized by sexual cold and bitter taste. The main functions are heat-clearing diuretic and dampness. The main components of borneol are L-Dragon's brain and a small amount of eucalyptus oil, L-camphor and sesquiterpene alcohol. Its characteristics are slightly cold, taste hard, and aromatic sputum. The main effect is to reduce swelling and pain, and to clear eyesight.
牡丹皮的主要成份是牡丹酚、 芍药甙、 挥发油等, 其特性为性微寒, 味 苦、 辛,主要功效是清热凉血, 活血化瘀。  The main ingredients of peony bark are peony phenol, peony peony, volatile oil, etc. Its characteristics are slightly cold, bitter and spicy, and its main effect is clearing heat and cooling blood, promoting blood circulation and removing blood stasis.
白鲜皮的主要成份是白鲜碱、茵芋碱、崖椒碱等,其特性为性寒,味苦,主 要功效是清热解毒, 除湿、 祛风和杀虫。  The main ingredients of white fresh skin are white fresh alkali, alkaloids, and jalapeno. Their characteristics are sexual cold and bitter taste. The main functions are detoxification, dehumidification, hurricane and insecticide.
本发明的药物, 具有清热利湿、 解毒止痒的功效, 主要用于湿热下注型, 症见瘙痒剧烈、 皮肤逐渐增厚、 色素沉积等病症。  The medicament of the invention has the effects of clearing heat and dampness, detoxifying and relieving itching, and is mainly used for damp-heat injection type, and the symptoms such as severe itching, thickening of the skin, pigmentation and the like.
本发明的治疗湿疹的中药软膏制剂的制备方法的工艺步骤是:  The process steps of the preparation method of the traditional Chinese medicine ointment preparation for treating eczema of the present invention are as follows:
1 )取苦参 300g、 白鲜皮 200g原料药材, 每次加 10倍量水, 煎煮 3次, 每次 2小时, 分别取煎液, 滤过, 合并滤液, 另置待用;  1) Take 300g of Sophora flavescens, 200g of raw material of white fresh skin, add 10 times of water each time, decoct 3 times, each time for 2 hours, take decoction separately, filter, combine the filtrate, and set it for use;
2)牡丹皮 300g原料药材, 加 20倍量水, 加热至 45eC, 温浸 1小时, 蒸 馏, 收集药材 10倍量蒸馏液, 滤过, 滤液中加入 5%氯化钠蒸馏, 收集药材 3 倍量蒸馏液, 冷藏, 析晶, 合并结晶, 得丹皮酚, 另置待用; 2) 300g raw material of peony bark, add 20 times of water, heat to 45 e C, immerse for 1 hour, distill, collect 10 times of distillate of medicinal material, filter, add 5% sodium chloride to the filtrate, collect the medicinal materials 3 times the amount of distillate, refrigerated, crystallization, combined crystallized, obtained paeonol, and set aside;
3)将步骤 2)所得药渣中加入 6倍量水, 煎煮 1小时, 滤过, 合并滤液, 另 置待用; 3) Add 6 times the amount of water to the dregs obtained in step 2), decoct for 1 hour, filter, and combine the filtrates, and use them separately;
4)合并步骤 1 )和步骤 3)滤液,浓缩至相对密度约为 1.06-1.10 (60°C ), 加乙醇使含醇量达 60%, 冷藏 24小时, 滤过, 减压回收乙醇(60〜70°C, -0.08Mpa), 浓缩至相对密度约为 1.28-1.35 (60°C ), 即得药物稠膏;  4) Combine the steps 1) and 3) the filtrate, concentrate to a relative density of about 1.06-1.10 (60 ° C), add ethanol to make the alcohol content 60%, refrigerate for 24 hours, filter, and recover ethanol under reduced pressure (60 ~70 ° C, -0.08 Mpa), concentrated to a relative density of about 1.28-1.35 (60 ° C), that is, a drug thick cream;
5 )取硬脂酸 150g 、羊毛脂 20g 、液体石蜡 250ml、甘油 50 g 、三乙醇 胺 8 g、 十二垸基硫酸钠 20 g、 水 370 ml制成基质, 与步骤 2)得丹皮酚, 步 骤 4)得药物稠膏及冰片 10g混合均匀,即可得治疗湿疹的药物软膏约 1000g。 本发明的有益效果是, 使用简单, 副作用小, 经临床实验证明, 总有效 率达到 80 %以上。 5) taking 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium decyl sulfate, 370 ml of water to prepare a matrix, and obtaining paeonol with step 2), Step 4) A drug ointment and 10 g of borneol are uniformly mixed to obtain about 1000 g of a drug ointment for treating eczema. The invention has the advantages of simple use, small side effects, and clinically proven that the total effective rate is over 80%.
具体实施方式 detailed description
本发明治疗湿疹的药物, 是由下述重量份配比的原料制成的药剂: 苦参 150^600 白鲜皮 100~300 牡丹皮 150〜600 冰片 5~25  The medicament for treating eczema of the present invention is a medicament prepared from the following raw materials by weight ratio: Sophora flavescens 150^600 white fresh skin 100~300 Mudanpi 150~600 borneol 5~25
本发明治疗湿疹药物最佳实施例按下述重量份配比的原料制成的药剂: 苦 参 300 白鲜皮 200 牡丹皮 300 冰 片 10  The preferred embodiment of the present invention for treating eczema is prepared according to the following raw materials by weight ratio: bitter ginseng 300 white fresh skin 200 peony bark 300 ice piece 10
该药物剂型为任何一种药剂学上所述的剂型, 均可实现发明目的。  The pharmaceutical dosage form is any of the pharmaceutically acceptable dosage forms, and the object of the invention can be achieved.
本发明治疗湿疹药物的软膏制备方法, 由于药物以治疗为主, 故抗菌消 炎作用尤为重要。 在工艺路线的设计上以保留有抗菌消炎的药效成分为主, 经祖国中医文献记载, 方中苦参的主要活性成分为苦参碱和氧化苦参碱等生 物碱类, 牡丹皮中主要有丹皮酚和芍药苷等, 根据以上研究, 可知该药物中 主要药物的活性成分比较明确, 确定工艺步骤如下:  The preparation method of the ointment for treating eczema according to the present invention is particularly important because the medicine is mainly treated, and the antibacterial and anti-inflammatory effect is particularly important. In the design of the process route, the antibacterial and anti-inflammatory medicinal ingredients are mainly preserved. According to the Chinese medicine literature of the motherland, the main active ingredients of Sophora flavescens are alkaloids such as matrine and oxymatrine, mainly in the peony bark. There are paeonol and paeoniflorin, etc. According to the above studies, it is known that the active ingredients of the main drugs in the drug are relatively clear, and the process steps are as follows:
1 )取苦参 300g、 白鲜皮 200g原料药材, 每次加 10倍量水, 煎煮 3次, 每次 2小时, 分别取煎液, 滤过, 合并滤液, 另置待用;  1) Take 300g of Sophora flavescens, 200g of raw material of white fresh skin, add 10 times of water each time, decoct 3 times, each time for 2 hours, take decoction separately, filter, combine the filtrate, and set it for use;
a、 苦参药材水提取工艺优选确定实验如下:  a. The water extraction process of Sophora flavescens is preferably determined as follows:
a.l、 预试验: 称取苦参 15 g、 白鲜皮 10 g药材, 粉碎成粗颗粒(10目左 右), 加水 6倍量, 煎煮 lh, 滤过, 放凉, 吸液量为 98ml, 吸液倍数为 2.08 倍量。 ,  Al, pre-test: Weigh 15 g of Sophora flavescens, 10 g of white fresh skin, smash into coarse particles (about 10 mesh), add 6 times of water, boil for 1 h, filter, let cool, absorb 98 ml. The absorption ratio is 2.08 times. ,
a.2、 正交试验: 根据预试验结果, 选择溶剂用量、 煎煮时间、 煎煮次数 3个因素, 每个因素 3个水平进行工艺优选, 因素水平表见表 -1。  A.2. Orthogonal test: According to the results of pre-test, choose three factors: solvent dosage, boiling time and boiling time. The process is preferred at three levels of each factor. The factor level table is shown in Table-1.
表 -1 水提工艺因素水平表: 水平因素 A B C Table-1 Level Table of Water Extraction Process Factors: Horizontal factor ABC
加水量(倍) 煎煮时间 (h) 煎煮次数(次) Water addition (times) boiling time (h) number of boiling times (times)
1 6 1 11 6 1 1
2 8 1.5 22 8 1.5 2
3 10 2 3 a.2.1正交试验方法: 3 10 2 3 a.2.1 Orthogonal test method:
a.2.1.1苦参碱的含量测定: 称取苦参粗颗粒 15g, 白鲜皮 10g, 按正交表 进行试验, 滤过, 滤液分别定容于相应量瓶中, 放冷, 分别加水至刻度, 摇 匀, 作为供试品溶液。精称已干燥恒重苦参碱对照品 2.80mg, 加甲醇使溶解, 转移至 5ml量瓶中, 作为对照品溶液。 精密吸取正交表下各工艺供试品溶液 各 lOul, 对照品溶液各 lOul和 5ul, 点于同一硅胶 G薄层板上, 以苯一丙酮 —乙酸乙酯一浓氨水(2: 3: 4: 0.2)为展开剂, 展开, 取出, 晾干, 用稀碘 化铋钾显色,在薄层板上覆盖同样大小的玻璃板,周围用胶布固定,用 CS-9301 薄层扫描仪进行扫描, 波长: X S =530nm, λ R=650nm,测量供试品吸收度积 分值与对照品吸收度积分值, 计算含量。  A.2.1.1 Determination of matrine content: Weigh 15g of Sophora flavescens coarse powder, 10g of white fresh skin, test according to the orthogonal table, filter, the filtrate is fixed to the corresponding volumetric flask, let cool, add water separately To the scale, shake well and serve as the test solution. The dried reference constant dry matrine reference substance 2.80mg, dissolved in methanol, transferred to a 5ml volumetric flask, as a reference solution. Precisely draw the lOul of each test solution under the orthogonal table, the lOul and 5ul of the reference solution, point on the same silica gel G thin plate, with benzene-acetone-ethyl acetate-concentrated ammonia (2: 3: 4) : 0.2) is a developing agent, unrolled, taken out, dried, and developed with dilute potassium iodide, covered with a glass plate of the same size on a thin layer, surrounded by a tape, and scanned with a CS-9301 thin layer scanner. , Wavelength: XS = 530nm, λ R = 650nm, measure the integral value of the absorbance of the test product and the absorbance integral value of the reference product, and calculate the content.
a.2.1.1出膏率的测定:按正交表进行试验,滤液分别定容于 1000 ml量瓶 中, 加水至刻度, 摇匀, 精取 50ml, 置已恒重的蒸发皿中, 水浴蒸干, 转移 至烘箱中, 80'C烘至干膏, 称重。  A.2.1.1 Determination of the creaming rate: According to the orthogonal test, the filtrate is set to 1000 ml volumetric flask, add water to the mark, shake well, take 50ml, place the constant weight of the evaporating dish, water bath Evaporate to dryness, transfer to an oven, bake at 80 ° C to dry paste, and weigh.
a.2.2正交试验结果及分析: 以苦参碱含量和出膏率为指标进行统计, 正 交试验结果汇总及分析见表 -2及表 -3、 表 -4。  A.2.2 Orthogonal test results and analysis: The matrine content and the ointment rate are used for the statistics. The summary and analysis of the orthogonal test results are shown in Table -2 and Table -3 and Table -4.
表 -2 苦参水提取工艺正交试验结果分析: Table -2 Analysis of orthogonal test results of Sophora flavescens water extraction process:
试验号 A B C D ~~苦参碱量(mg/g药材) ~~出膏率( %) Test No. A B C D ~~ matrine amount (mg/g medicinal material) ~~ creaming rate (%)
1 1 1 1 1 1.809 13.51  1 1 1 1 1 1.809 13.51
2 1 2 2 2 5.928 24.31  2 1 2 2 2 5.928 24.31
3 1 3 3 3 6.719 28.34  3 1 3 3 3 6.719 28.34
4 2 1 2 3 5.230 22.22  4 2 1 2 3 5.230 22.22
5 2 2 3 1 6.943 27.94 6 2 1 3 2 3.540 18.565 2 2 3 1 6.943 27.94 6 2 1 3 2 3.540 18.56
7 3 1 3 2 5.763 26.287 3 1 3 2 5.763 26.28
8 3 2 1 3 3.671 17.158 3 2 1 3 3.671 17.15
9 3 3 2 1 6.801 26.189 3 3 2 1 6.801 26.18
I 14.456 12.802 9.02 15.553 苦参碱 I 14.456 12.802 9.02 15.553 Matrine
II 15.713 16.542 17.959 15.231  II 15.713 16.542 17.959 15.231
ΠΙ 16.235 17.06 19.425 15.62  ΠΙ 16.235 17.06 19.425 15.62
R 1.779 4.258 10.405 0.389  R 1.779 4.258 10.405 0.389
I 66.16 62.01 49.22 67.63 出膏率  I 66.16 62.01 49.22 67.63 Erasing rate
II 68.72 69.40 72.71 69.15  II 68.72 69.40 72.71 69.15
ΠΙ 69.61 73.08 82.56 67.71  ΠΙ 69.61 73.08 82.56 67.71
R 3.45 . 11.07 33.34 1.52  R 3.45 . 11.07 33.34 1.52
对所得结果进行方差分析, 结果如下: The analysis of variance was performed on the results obtained. The results are as follows:
苦参碱正交试验结果方差分析:  Analysis of variance of maternal orthogonal test results:
Figure imgf000008_0001
表 "4 出膏率正交试验结果方差分析:
Figure imgf000008_0001
Table "4 Analysis of Variance of Orthogonal Test Results of Ointment Rate:
方差来源 离差平方和 自由度 方差 F值 Variance source deviation square sum degree freedom degree variance F value
A 2.1387 2 1.0694 4.38A 2.1387 2 1.0694 4.38
B 21.1888 2 10.5944 43.44B 21.1888 2 10.5944 43.44
C 195.5954 2 97.7977 400.97C 195.5954 2 97.7977 400.97
D 0.4878 2 0.2439 F0.05(2,2)=19.0 F0.01(2,2)=99.0 D 0.4878 2 0.2439 F0.05(2,2)=19.0 F0.01(2,2)=99.0
研究结果, 从苦参碱溶出量看, 提取次数 C为主要影响因素, 其中, C3>C2>C1 , 所以选择 C3水平; B因素也为主要因素, 但是结合极差分析结 果, B2、 B3水平相差不大, 但与 B1有较大的差异, 因此, 可选择 B3水平; 在 A因素中, A2、 A3水平相差不大, 但与 A1有较大的差异, 因此, 可选 择 A3水平, 故优选的工艺条件为 A3B3C3; 从出膏率看, B、 C都为显著性 因素,但正交表中以 3为最髙, 即 A1B3C3,故综合考虑取 A3B3C3为最佳条 件, 即药材加入 10倍量水, 煎煮 3次, 每次 2小时。  According to the results of the study, the extraction number C is the main influencing factor, and C3>C2>C1, so the C3 level is selected; the B factor is also the main factor, but combined with the results of the range analysis, B2 and B3 levels. There is not much difference, but there is a big difference with B1. Therefore, the B3 level can be selected. In the A factor, the A2 and A3 levels are not much different, but there is a big difference with A1. Therefore, the A3 level can be selected. The preferred process conditions are A3B3C3; B and C are significant factors in terms of the creaming rate, but 3 is the most ambiguous in the orthogonal table, namely A1B3C3, so the comprehensive consideration of A3B3C3 is considered as the best condition, that is, the medicine is added to 10 Double the amount of water, decoct 3 times, 2 hours each time.
a.2.3验证试验: 根据正交试验确定的条件平行操作两次, 以苦参碱和出 膏率为指标, 进行验证试验, 并按工艺优选中的最优工艺 A3B3C3做了比较 试验, 结果见下表。 表明优选的工艺好于参比工艺, 所确定工艺为较好工艺。 表 -5苦参水提取工艺验证试验结果:  A.2.3 Verification test: According to the conditions determined by the orthogonal test, the operation is performed in parallel twice, and the verification test is carried out with the matrine and the ointment rate as indicators. The comparison test is carried out according to the optimal process A3B3C3 in the process optimization. The following table. It indicates that the preferred process is better than the reference process, and the determined process is a better process. Table -5 Results of the verification process of the extraction process of Sophora flavescens water:
Figure imgf000009_0001
Figure imgf000009_0001
2)牡丹皮 300g原料药材, 加 20倍量水, 加热至 45°C, 温浸 1小时, 蒸 馏, 收集药材 10倍量蒸馏液, 滤过, 滤液中加入 5%氯化钠蒸熘, 收集药材 3 倍量蒸馏液, 冷藏, 析晶, 合并结晶, 得丹皮酚, 另置待用; 2) 300 g of raw material of peony bark, add 20 times of water, heat to 45 ° C, immerse for 1 hour, distill, collect 10 times of distillate of medicinal material, filter, add 5% sodium chloride to the filtrate, collect 3 times the amount of distillate of the medicinal material, refrigerated, crystallization, combined with crystallization, obtained paeonol, and set aside;
3)将步骤 2)所得药渣中加入 6倍量水, 煎煮 1小时, 滤过, 合并滤液, 另置待用;  3) Add 6 times of water to the obtained dregs of step 2), decoct for 1 hour, filter, and combine the filtrates for use;
4)合并步骤 1 )和步骤 3)滤液, 浓缩至相对密度约为 1.06-1.10 (60°C ), 加乙醇使含醇量达 60%, 冷藏 24小时, 滤过, 减压回收乙醇(60〜70°C , -0.08Mpa), 浓縮至相对密度约为 1.28-1.35 (60"C ), 即得药物稠膏;  4) Combine the steps 1) and 3) the filtrate, concentrate to a relative density of about 1.06-1.10 (60 ° C), add ethanol to make the alcohol content 60%, refrigerate for 24 hours, filter, and recover ethanol under reduced pressure (60 ~70 ° C, -0.08 Mpa), concentrated to a relative density of about 1.28-1.35 (60" C), that is, a drug thick cream;
a牡丹皮药材双提法工艺优选确定如下: a.l药材中丹皮酚的提取实验如下- a.1.1牡丹皮以丹皮酚成分为主, 为尽可能地最大限度提出, 又不使高分 子黏性物质过多溶出, 使滤过困难, 还耗能耗时, 我们采用双提法, 通过优 选条件, 使之在尽可能短的时间内既尽可能多的提取有效成分, 又可以保持 传统汤剂的特色。 The selection process of a peony skin medicinal material is preferably determined as follows: The extraction experiment of paeonol in al medicinal materials is as follows - a.1.1 peony bark is mainly composed of paeonol, which is proposed as much as possible without excessive dissolution of polymer viscous material, which makes filtration difficult. When energy consumption is used, we use the double extraction method to optimize the extraction of the active ingredients as much as possible in the shortest possible time, and to maintain the characteristics of the traditional decoction.
先将牡丹皮药材粗粉碎, 使之 "细而不粉", 既可增大表面积利于成分溶 出, 又不致糊化影响成分的溶出及滤过。 此外, 为尽量保持汤剂的特色, 又 兼顾水溶性成分, 故设计了考察加水倍数、 药材的前处理及加盐量 3个因素 进行比较试验。  Firstly, the peony skin material is coarsely pulverized to make it "fine but not powder", which can increase the surface area to facilitate the dissolution of the components, and does not cause the gelatinization to affect the dissolution and filtration of the components. In addition, in order to maintain the characteristics of the decoction as much as possible, and to take into account the water-soluble ingredients, three factors, including the water addition ratio, the pretreatment of the medicinal material and the salt addition amount, were designed for comparative tests.
a.1.2预试验:我们进行了提取丹皮酚的预试验,称取牡丹皮 20g,置 500ml 圆底烧瓶中, 蒸熘法提取, 收集不同体积蒸馏液, 冷藏析晶, 滤过, 滤液加 5%氯化钠蒸馏, 收集 3倍蒸馏液, 冷藏析晶, 滤过, 滤液用乙醚提取 3次, 每次 50ml, 挥干乙醚, 将结晶合并, 40°C干燥 1小时, 称重, 结果如下: 提取丹皮酚预试验结果:  A.1.2 Pre-test: We carried out a pre-test for extracting paeonol, weighed 20g of peony bark, placed it in a 500ml round bottom flask, extracted by steaming, collected different volumes of distillate, refrigerated and crystallized, filtered, and filtrate added. Distilled with 5% sodium chloride, collected 3 times distillate, recrystallized and crystallized, filtered, and the filtrate was extracted with diethyl ether three times, 50 ml each time, and the ether was evaporated. The crystals were combined, dried at 40 ° C for 1 hour, and weighed. As follows: Extraction of paeonol pre-test results:
Figure imgf000010_0001
由结果看, 收集 10倍蒸馏液较为适宜。
Figure imgf000010_0001
From the results, it is appropriate to collect 10 times of distillate.
a.1.3正交试验: 根据预试验的结果, 我们进行了 3因素 3水平的正交试 验, 来优选双提法的最佳工艺。  A.1.3 Orthogonal test: Based on the results of the preliminary test, we performed an orthogonal test of 3 factors and 3 levels to optimize the optimal process of double extraction.
a.1.3.1 因素水平表: 根据预试验的结果, 设计出了双提法正交试验的因 素水平表, 见表 -7。  A.1.3.1 Factor level table: According to the results of the pre-test, the factor level table of the double-rectification orthogonal test is designed, see Table -7.
表 -7 丹皮酚提取因素水平表:  Table -7 Paeonol extraction factor level table:
水平 A B C 加水倍量 药材前处理 加盐量 (%)Horizontal ABC Add water to pre-treatment and add salt (%)
1 15 不浸泡 01 15 Do not soak 0
2 20 冷浸 lh 52 20 cold soak lh 5
3 25 温浸 lh 10 a丄 3.2试验方法: 称取牡丹皮 100g (粗粉碎过 10目筛), 按表 -8中正交 试验列号项下的试验条件, 温控时间控制在 45°C左右, 蒸馏法提取, 收集 10 倍蒸馏液, 冷藏析晶, 滤过, 滤液加 5%氯化钠蒸镏, 收集 3倍蒸馏液, 冷藏 析晶, 滤过, 合并结晶物, 40Ό干燥, 称重, 比较。 以丹皮酚得量 (g) 为指 标, 进 ¾统计。 正交试验结果见表 -8。 3 25 Warming lh 10 a丄3.2 Test method: Weigh 100g of peony bark (roughly crushed through 10 mesh sieve), according to the test conditions under the orthogonal test column number in Table-8, the temperature control time is controlled at 45 °C. Left and right, extract by distillation, collect 10 times of distillate, recrystallize and crystallize, filter, filtrate and add 5% sodium chloride to distillate, collect 3 times of distillate, recrystallize and crystallize, filter, crystallize, 40 Ό dry, weigh Heavy, comparison. The paeonol yield (g) is used as an indicator to enter the statistics. The results of the orthogonal test are shown in Table -8.
表 -8 丹皮酚提取正交试验及结果分析: 试验号 A B C D 丹皮酚重 (g) Table -8 Orthogonal test and analysis of paeonol extraction: Test No. A B C D Paeonol Weight (g)
1 1 1 1 1 1. 064  1 1 1 1 1 1. 064
2 1 2 2 2 1. 308  2 1 2 2 2 1. 308
3 1 3 3 3 1. 331  3 1 3 3 3 1. 331
4 2 1 2 3 1. 334  4 2 1 2 3 1. 334
5 2 2 3 1 1. 312  5 2 2 3 1 1. 312
6 2 3 1 2 1. 193  6 2 3 1 2 1. 193
7 3 1 3 2 1. 225  7 3 1 3 2 1. 225
8 3 2 1 3 1. 141  8 3 2 1 3 1. 141
9 3 3 2 1 1. 337  9 3 3 2 1 1. 337
I 3. 703 3. 623 3. 398 3. 713  I 3. 703 3. 623 3. 398 3. 713
II 3. 839 3. 761 3. 979 3. 726  II 3. 839 3. 761 3. 979 3. 726
ΙΠ 3. 703 3. 861 3. 868 3. 806  ΙΠ 3. 703 3. 861 3. 868 3. 806
R 0. 136 0. 238 0. 581 0. 093 对所得结果进行方差分析, 结果如下: 表 -9 丹皮酚提取正交试验结果极差分析:  R 0. 136 0. 238 0. 581 0. 093 The results obtained were analyzed by ANOVA. The results are as follows: Table -9 Analysis of the results of orthogonal test of paeonol extraction:
Figure imgf000011_0001
Figure imgf000011_0001
°1 D 0. 001691 2 0. 000846 °1 D 0. 001691 2 0. 000846
F0.05 (2,2)=19.0 F0.01 (2,2)=99.0 F0.05 (2,2)=19.0 F0.01 (2,2)=99.0
根据以上分析, C为主要因素, 应选优水平 C2, A、 B为次要因素, 结 合经济省时优选, 应选 A 1和 B1, 但考虑到大生产设备出液慢, 蒸馏时间应 延长, 同时考虑水溶性成分的溶出, 可选择 A2, 因温浸可加快蒸馏时间, 故 优选丹皮酚提取工艺为 A2B3C2, 即药材加 20倍量水, 先温浸 1小时, 再蒸 馏提取, 且二次蒸馏加 5β/。氯化钠。 According to the above analysis, C is the main factor, should choose the best level C2, A, B are secondary factors, combined with economic and provincial time preference, should choose A 1 and B1, but considering the slow discharge of large production equipment, the distillation time should be extended At the same time, considering the dissolution of water-soluble components, A2 can be selected, because the temperature immersion can speed up the distillation time, so the extraction process of paeonol is preferably A2B3C2, that is, the medicinal material is added with 20 times of water, first immersed for 1 hour, and then distilled and extracted, and Secondary distillation plus 5 β /. Sodium chloride.
a.1.3.3 验证试验: 我们进行了提取丹皮酚的验证试验, 按处方比例, 准 确称取牡丹皮 100g, 按照确定工艺实验条件操作 2次, 加 20倍量水, 蒸馏法 提取丹皮酚, 并按工艺正交表中直观分析最优水平的 9号实验 A3B3C2做了 比较试验, 结果见下表, 表明优选的工艺与 A3B3C2所得结果相差无几, 所 确定工艺为较好工艺。  A.1.3.3 Verification test: We carried out the verification test of extracting paeonol. According to the proportion of prescription, accurately weigh 100g of peony bark, operate 2 times according to the experimental conditions, add 20 times of water, extract the paeonol by distillation. Phenol, and a comparative test of No. 9 experiment A3B3C2, which is intuitively analyzed in the orthogonal table of the process, was carried out. The results are shown in the table below, indicating that the preferred process is comparable to that obtained by A3B3C2, and the determined process is a better process.
表 -10丹皮酚提取验证试验结果表:
Figure imgf000012_0001
a,2 水煎煮部分煎煮次数的考察:
Table-10 Table of results of paeonol extraction verification test:
Figure imgf000012_0001
a, 2 water boiling partial boiling times:
蒸馏后的水液滤过后, 药渣仍含水溶性成分, 由于已经过.长时间蒸馏, 再经 短时间煎煮即可, 因第一次煎煮药材已被充分润胀, 因此第二煎加液量定为 6 倍量, 我们以乙醇浸出物得率为指标, 对提丹皮酚药材的煎煮次数进行了考 察。 After the filtered water is filtered, the dregs still contain water-soluble components. Since it has been distilled for a long time, it can be boiled for a short time. Because the first decoction has been fully swelled, the second frying is added. The amount of liquid was determined to be 6 times. We used the yield of ethanol extract as an indicator to investigate the number of decoctions of the drug.
a.2.1试验方法: 称取牡丹皮 100g, 根据优选得到的条件进行试验, 提丹 皮酚完毕后, 滤过, 收集药液作为样 1, 药渣加 6倍量水进行 2煎、 3煎, 每 次 1小时, 滤过, 分别收集药液, 得样 2、 样 3, 3份样品分别浓缩至 100ml (60'C ), 加等体积的乙醇, 使醇溶性成分溶出, 冷藏 24小时, 滤过, 滤液 浓缩至干, 于烘箱中烘至恒重 (105eC ), 称重, 减去蒸发皿重量, 即得乙醇 浸出物得量。 A.2.1 Test method: Weigh 100g of peony bark, and test according to the preferred conditions. After the extraction of paeonol, filter it, collect the drug solution as sample 1, add 6 times of water to the dregs, and fry 2 , every time for 1 hour, filter, collect the liquid, get sample 2, sample 3, 3 samples are separately concentrated to 100ml (60'C), add an equal volume of ethanol, so that the alcohol-soluble components are dissolved, refrigerated for 24 hours, Filtration, filtrate Concentrate to dryness, bake in an oven to constant weight (105 e C), weigh, and subtract the weight of the evaporating dish to obtain the amount of ethanol extract.
a.2.2试验结果及分析见表 -11  A.2.2 Test results and analysis are shown in Table -11
表- 11 提丹皮酚后药材煎煮次数考察结果  Table - 11 Results of decoction times of pecan phenolic herbs
Figure imgf000013_0001
由以上试验数据分析可知, 第三煎所得乙醇浸出物的重量仅占三煎总浸 出物的 4%, 且在试验过程中, 经外观分析, 样 1为深棕色, 样 2为浅棕色 样 3 仅为淡红色, 从节省时间, 节约能源角度出发, 确定水煎煮部分煎煮 2 次。
Figure imgf000013_0001
From the above test data analysis, the weight of the ethanol extract obtained by the third decoction only accounted for 4% of the total decoction of Sanjian, and during the test, the appearance 1 was dark brown, and the sample 2 was light brown. It is only light red. From the perspective of saving time and saving energy, make sure that the water is boiled and boiled twice.
a.2.3验证试验: 我们进行了提取丹皮酚后药渣煎煮次数的验证试验, 按 处方比例, 准确称取牡丹皮 lKg, 按照确定工艺实验条件操作, 结果见下表, 表明药材提取丹皮酚后, 再加 6倍量水煎煮 lh即可。  A.2.3 Verification test: We carried out the verification test of the number of decoction of the dregs after extracting paeonol. According to the proportion of prescription, we accurately weighed lKg of peony bark and operated according to the experimental conditions. The results are shown in the table below, indicating that the medicinal material is extracted. After the phenol, add 6 times the amount of water to cook for 1 hour.
表 -12 牡丹皮药材提取次数验证试验结果表:  Table -12 Table of results of verification test of the extraction times of peony skin material:
试 验 次数 Ϊ 2  Number of trials Ϊ 2
前二煎醇浸出物比例 (%) 95.08 95.17  The ratio of the first two fried alcohol extracts (%) 95.08 95.17
第三煎醇浸出物比例 (%) 4.92 4.83 b、水煎液醇沉工艺优选:根据提取工艺优选所得结果,水煎煮得膏达 40% 左右, 经醇沉后, 得膏率可大大降低, 醇沉可除去果胶、 淀粉等高分子杂质, 以达进一步精制的目的。 因此可将水提液浓缩后采用醇沉工艺进行精制。 实 验中比较了醇沉使含醇量达 40%, 50%, 60%, 70%的除杂效果。  The proportion of the third decocted alcohol extract (%) 4.92 4.83 b, the decoction alcohol precipitation process is preferred: according to the extraction process preferred results, water decoction to achieve a paste of about 40%, after the alcohol precipitation, the paste rate can be greatly reduced The alcohol precipitation can remove polymer impurities such as pectin and starch to achieve further purification. Therefore, the aqueous extract can be concentrated and then refined by an alcohol precipitation process. In the experiment, the alcohol precipitation was compared to make the alcohol content up to 40%, 50%, 60%, and 70%.
试验方法: 按处方比例称取苦参 75g、 白鲜皮 50 g, 共 175g, 粗粉碎, 按工艺优选所得最佳条件进行提取, 合并滤液; 再取牡丹皮 50g, 采用蒸馏法 提取, 合并滤液, 再与上述药液合并, 继续浓缩至相对密度为 1.06 (60°C ), 约 175 ml。 Test method: According to the prescription ratio, weighed 75g of Sophora flavescens and 50g of white fresh skin, a total of 175g, coarsely crushed, According to the optimal conditions obtained by the process, the filtrate is combined; 50 g of peony bark is taken, extracted by distillation, and the filtrate is combined, and then combined with the above solution, and further concentrated to a relative density of 1.06 (60 ° C), about 175 ml. .
将上述药液均分为五份, 一份定容至 100 ml, 其余四份分别加乙醇使其 醇浓度达 40%, 50%, 60%, 70%, 冷藏, 静置过夜, 过滤, 充分洗涤滤渣, 回收乙醇, 分别定容至 100 ml, 直接点样, 测定苦参碱。 另精密量取 20 ml 药液浓縮至干, 测各份样品的得膏率。 另将干膏粉转移至 100ml圆底烧瓶中, 加入 50 ml无水乙醇回流 1小时, 滤过, 滤液水浴蒸至约 5ml, 转移至 5 ml 量瓶中, 加无水乙醇至刻度, 测其中芍药苷的含量, 结果见表 -13:  Divide the above liquid into five parts, one part to 100 ml, and the other four parts with ethanol to make the alcohol concentration 40%, 50%, 60%, 70%, refrigerate, stand overnight, filter, fully The filter residue was washed, ethanol was recovered, and the volume was adjusted to 100 ml, and the sample was directly sampled to determine matrine. In addition, 20 ml of the drug solution was accurately weighed to dryness, and the obtained paste rate of each sample was measured. The dry paste powder was transferred to a 100 ml round bottom flask, refluxed with 50 ml of absolute ethanol for 1 hour, filtered, and the filtrate was steamed to about 5 ml in a water bath, transferred to a 5 ml volumetric flask, and anhydrous ethanol was added to the mark to measure The content of paeoniflorin, the results are shown in Table-13:
表 -13 不同浓度醇沉除杂效果的比较: Table -13 Comparison of different concentrations of alcohol precipitation and impurity removal:
醇沉浓度 苦参碱 (mg/g药材) 干膏率(%) 芍药苷含量(mg/g药材) Alcohol concentration Matrine (mg/g medicinal material) Dry paste rate (%) Paeoniflorin content (mg/g medicinal material)
原药液 6.558 38.75 9.308 Original liquid 6.558 38.75 9.308
40%乙醇 5.352 17.90 3.825  40% ethanol 5.352 17.90 3.825
50%乙醇 5.504 14.70 5.730  50% ethanol 5.504 14.70 5.730
60%乙醇 6.285 11.59 7.762  60% ethanol 6.285 11.59 7.762
70%乙醇 5.994 10.99 7.458 从实验中可以看出, 60%, 70%醇沉去除杂质较多, 但 60%醇沉苦参碱和 芍药苷的含量保留较多, 且较经济, 因此我们最终选定醇沉的浓度为 60%。  70% ethanol 5.994 10.99 7.458 It can be seen from the experiment that 60%, 70% alcohol precipitation removes more impurities, but the content of 60% alcohol matrine and paeoniflorin is more reserved and economical, so we finally choose The concentration of the alcohol precipitate was 60%.
c、 浓缩工艺研究:  c. Concentration process research:
( 1 )水提取液浓缩至相对密度为 1.06-1.10(60eC测),加入乙醇沉淀较好。 药液相对密度低于 1.06时, 药液浓度较稀, 用醇量较大; 药液相对密度高于 1.10 时, 药液浓度较大, 醇沉时药液不易分散均匀。 将水提取液采取三效减 压浓缩, 效率髙。 (1) The water extract is concentrated to a relative density of 1.06-1.10 (60 e C), and ethanol precipitation is preferred. When the relative density of the liquid is less than 1.06, the concentration of the liquid is relatively thin, and the amount of alcohol is large; when the relative density of the liquid is higher than 1.10, the concentration of the liquid is large, and the liquid is not easily dispersed even when the alcohol is sedimented. The water extract is concentrated by three-effect decompression, and the efficiency is low.
(2)处方中的水煎部分按以上所优选的条件进行提取和醇沉后, 滤液进 行减压回收乙醇 (60~70'C, -0.08Mpa)时, 尽量低温进行, 以免有效成分破坏。  (2) The water-decoction portion of the prescription is extracted and alcohol-precipitated according to the above preferred conditions, and the filtrate is subjected to reduced pressure recovery of ethanol (60-70'C, -0.08 Mpa), and the temperature is kept as low as possible to avoid destruction of the active ingredient.
β 回收乙醇后, 继续浓缩至相对密度为 1.28-1.35(60Ό测)的浓浸膏较为适 宜, 易与基质混合均勾。 实验表明浸膏相对密度低于 1.28, 与基质混合后, 软膏较稀, 稳定性达不到要求: 浸膏相对密度高于 1.35, 与基质难于混合, 不易混合均匀。 β After recovering the ethanol, it is more suitable to continue to concentrate to a concentrated extract having a relative density of 1.28-1.35 (60 Ό), which is easy to mix with the matrix. Experiments have shown that the relative density of the extract is less than 1.28. After mixing with the matrix, the ointment is thinner and the stability is not satisfactory. The relative density of the extract is higher than 1.35, which is difficult to mix with the matrix and is not easy to mix evenly.
5)取硬脂酸 150g 、 羊毛脂 20g 、 液体石蜡 250ml、 甘油 50 g 、 三乙醇 胺 8 g、 十二烷基硫酸钠 20 g 、 水 370 ml制成基质, 与步骤 2) 得丹皮酚, 步骤 4) 得药物稠膏及冰片 10g 混合均匀, 即可得治疗湿疹的药物软膏约 1000g。  5) taking 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium lauryl sulfate, 370 ml of water to prepare a matrix, and step 2) to obtain paeonol. Step 4) After the drug thick cream and the borneol 10g are uniformly mixed, a pharmaceutical ointment for treating eczema can be obtained by about 1000 g.
本发明软膏基质的筛选: 按照下列基质处方制成基质, 然后采用研和法 与药物浓膏混合。 采用皮肤刺激和耐热、 耐寒试验作为指标进行优选。  Screening of the ointment base of the present invention: The base is prepared according to the following matrix formulation, and then mixed with the drug cream by a grinding method. It is preferred to use skin irritation and heat resistance and cold resistance tests as indicators.
结果见表 -14:  The results are shown in Table -14:
(1) 羊毛脂 30g 凡士林 400g 尼泊金乙酯 0. 5g (1) Lanolin 30g Vaseline 400g Paraben ethyl ester 0. 5g
(2) 硬脂酸 160g 单硬脂酸甘油酯 60g 凡士林 60g  (2) Stearic acid 160g glyceryl monostearate 60g Vaseline 60g
羊毛脂 80g 液体石蜡 12g 氮 酮 20 g  Lanolin 80g liquid paraffin 12g azone ketone 20 g
甘油 80g 尼泊金乙酯 2g 三乙醇胺 8g 水 480 ml  Glycerin 80g ethylparaben 2g triethanolamine 8g water 480 ml
(3) 十八醇 200g 凡士林 200g 液体石蜡 120ml  (3) octadecyl alcohol 200g petroleum jelly 200g liquid paraffin 120ml
甘油 100 g 尼泊金乙酯 2g 月桂醇硫酸钠 20g  Glycerin 100 g ethylparaben 2g sodium lauryl sulfate 20g
氮酮 20 g 水 350 ml  Azone 20 g water 350 ml
(4) 硬脂酸 150g 羊毛脂 20g 液体石蜡 250ml 甘油 50g  (4) Stearic acid 150g Lanolin 20g Liquid paraffin 250ml Glycerin 50g
三乙醇胺 8g 十二烷基硫酸钠 20g 水 450ml 表 -14 基质优选结果  Triethanolamine 8g sodium lauryl sulfate 20g water 450ml Table -14 Matrix Preferred Results
软硬度 皮肤刺激性 耐热实验 耐寒实验  Softness, skin irritation, heat resistance test, cold resistance experiment
( 1 ) 硬度大 粘稠 耐 55。C 耐 -15。C (2) 软度大 易涂布 不耐 45'C 不耐 -15°C (1) Hardness is viscous and resistant to 55. C resistant to -15. C (2) Softness is easy to apply and is not resistant to 45'C.
(3) 软硬适宜 易涂布 不耐 45 °C 不耐 -15eC (3) Soft and hard, easy to apply, not tolerant to 45 °C, not resistant to -15 e C
(4) 软硬适宜 易涂布 耐 55。C 耐 -15°C 由结果分析, 基质(4)较为合适。 即硬脂酸 150g 、 羊毛脂 20g、 液体 石蜡 250ml、 甘油 50g、 三乙醇胺 8g、 十二垸基硫酸钠 20g、 水 450ml。 ,  (4) Soft and hard, easy to apply, resistant to 55. C resistance -15 ° C From the results analysis, the matrix (4) is more suitable. Namely, 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium decyl sulfate, and 450 ml of water. ,

Claims

权利要求书 Claim
1、 一种治疗湿疹的药物, 其特征在于: 该药物是由下述重量份配比的原料制 成的药剂:  A medicament for treating eczema, characterized in that: the medicament is an medicament made of the following raw materials by weight:
苦 参 150~600 白鲜皮 100〜300 牡丹皮 150〜600 冰 片 5~25 Bitter ginseng 150~600 white fresh skin 100~300 peony skin 150~600 ice piece 5~25
2、 根据权利要求 1所述的治疗湿疹的药物, 其特征在于: 其中各原料的重量 份配比是:  2. The medicament for treating eczema according to claim 1, wherein: the weight ratio of each raw material is:
苦 参 300 白鲜皮 200 牡丹皮 300 冰 片 10 Kushen 300 white fresh skin 200 peony skin 300 ice sheet 10
3、 根据权利要求 1或 2所述的治疗湿疹药物的软膏制备方法, 其特征在于: 该方法的工艺步骤如下:  The method for preparing an ointment for treating eczema according to claim 1 or 2, wherein the process steps of the method are as follows:
1 )取苦参 300g、 白鲜皮 200g原料药材, 每次加 10倍量水, 煎煮 3次, 每次 2小时, 分别取煎液, 滤过, 合并滤液, 另置待用;  1) Take 300g of Sophora flavescens, 200g of raw material of white fresh skin, add 10 times of water each time, decoct 3 times, each time for 2 hours, take decoction separately, filter, combine the filtrate, and set it for use;
2) 牡丹皮 300g原料药材, 加 20倍量水, 加热至 45'C , 温浸 1小时, 蒸馏, 收集药材 10倍量蒸馏液, 滤过, 滤液中加入 5%氯化钠蒸镏, 收集药材 3倍 量蒸馏液, 冷藏, 析晶, 合并结晶, 得丹皮酚, 另置待用;  2) 300g raw material of peony bark, add 20 times of water, heat to 45'C, immerse for 1 hour, distill, collect 10 times of distillate of medicinal material, filter, add 5% sodium chloride to the filtrate, collect 3 times the amount of distillate of the medicinal material, refrigerated, crystallization, combined crystallized, obtained paeonol, and used separately;
3)将步骤 2) 所得药渣中加入 6倍量水, 煎煮 1小时, 滤过, 合并滤液, 另 置待用;  3) Add 6 times of water to the dregs obtained in step 2), decoct for 1 hour, filter, and combine the filtrates for use;
4) 合并步骤 1 ) 和步骤 3) 滤液, 浓缩至相对密度约为 1.06-1.10 (60°C ), 加 乙醇使含醇量达 60%, 冷藏 24 小时, 滤过, 减压回收乙醇 (60〜70。C, -0.08Mpa), 浓缩至相对密度约为 1.28-1.35 (60°C ), 即得药物稠膏  4) Combine the steps 1) and 3) the filtrate, concentrate to a relative density of about 1.06-1.10 (60 ° C), add ethanol to make the alcohol content 60%, refrigerate for 24 hours, filter, and recover ethanol under reduced pressure (60 ~70.C, -0.08Mpa), concentrated to a relative density of about 1.28-1.35 (60 ° C), that is, a drug thick paste
5)取硬脂酸 150g 、羊毛脂 20g 、液体石蜡 250ml、甘油 50 g、三乙醇胺 8 g、 十二烷基硫酸钠 20 g、 水 370 ml制成基质, 与步骤 2)得丹皮酚, 步骤 4)得 药物稠膏及冰片 10g混合均匀, 即可得治疗湿疹的药物软膏约 1000g。  5) taking 150 g of stearic acid, 20 g of lanolin, 250 ml of liquid paraffin, 50 g of glycerin, 8 g of triethanolamine, 20 g of sodium lauryl sulfate, 370 ml of water to prepare a matrix, and step 2) to obtain paeonol. Step 4) The drug thick cream and the borneol 10g are uniformly mixed, and about 1000 g of the medical ointment for treating eczema can be obtained.
PCT/CN2007/003272 2006-11-20 2007-11-20 A medicine for treating eczema and process of ointment thereof WO2008061447A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200610156942.4 2006-11-20
CN2006101569424A CN101019952B (en) 2006-11-20 2006-11-20 Medicine for treating eczema and preparation process of its ointment

Publications (1)

Publication Number Publication Date
WO2008061447A1 true WO2008061447A1 (en) 2008-05-29

Family

ID=38707878

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/003272 WO2008061447A1 (en) 2006-11-20 2007-11-20 A medicine for treating eczema and process of ointment thereof

Country Status (2)

Country Link
CN (1) CN101019952B (en)
WO (1) WO2008061447A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104274722A (en) * 2014-09-24 2015-01-14 江苏奇力康皮肤药业有限公司 Traditional Chinese medicinal composition for treating eczema and preparation method thereof
CN104689084B (en) * 2015-04-07 2018-08-17 贵阳名草堂绿色植物科技开发中心 A kind of liniment for treating allergic dermatitis
CN105920219A (en) * 2016-04-20 2016-09-07 陈程辉 Medicine for treating eczema
CN106511410A (en) * 2017-01-03 2017-03-22 遵义医学院 Herba Saxifragae ointment for treating skin diseases and preparation method of Herba Saxifragae ointment for treating skin diseases
CN107095914A (en) * 2017-06-28 2017-08-29 何家平 A kind of antipruritic medium-height grass liquid medicine and preparation method thereof
CN112933237A (en) * 2020-12-28 2021-06-11 上海奥茵特生物科技有限公司 Composite traditional Chinese medicine patch for treating epidermal thickening and pruritic skin diseases
CN114470050B (en) * 2022-03-21 2023-09-05 上海相宜本草化妆品股份有限公司 A Chinese medicinal composition for resisting sensitization, relieving itching and/or repairing skin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1125117A (en) * 1994-12-22 1996-06-26 昆明市火炬科技开发实业公司 Ointment for curing eczema

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056531C (en) * 1997-08-29 2000-09-20 刘进成 Chinese medicinal herb composition for treating skin disease
CN1325083C (en) * 2005-10-24 2007-07-11 高欲林 Medicinal composition for removing dampness to relieve itching and its preparation method and uses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1125117A (en) * 1994-12-22 1996-06-26 昆明市火炬科技开发实业公司 Ointment for curing eczema

Also Published As

Publication number Publication date
CN101019952A (en) 2007-08-22
CN101019952B (en) 2011-01-12

Similar Documents

Publication Publication Date Title
CN102178804B (en) Chinese medicinal composition for treating perianal eczema and preparation method thereof
CN102205107B (en) Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
WO2008061447A1 (en) A medicine for treating eczema and process of ointment thereof
Wang et al. Ethnopharmacological use, pharmacology, toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii Debeaux.(Fuzi): a review
CN101920002B (en) Chinese medicinal formula for treating gout and hyperuricemia
CN103479963A (en) Traditional Chinese medicine capsules for treating rheumatoid arthritis and preparation method thereof
CN104352624B (en) Application of the anaesthetic core fragrant plant n-butanol extract in preventing and treating diabetes medicament is prepared
CN102228551B (en) Chinese medicinal composition for preventing and treating injury of gastric mucosa and preparation method thereof
CN103877438A (en) Traditional Chinese medicine preparation for treating gout and production method thereof
CN103610795B (en) A kind of preparation method of eucommia bark depressor oral formulations
CN102293928A (en) Chinese medicinal composition for treating hyperuricemia and urarthritis, and preparation method and application thereof
CN105233150A (en) Traditional Chinese medicine composition and application thereof
CN109248188A (en) A kind of preparation method and applications of goldspink root extract
CN101869675B (en) Chinese medicinal composition granules for treating summer-heat damp cold and preparation method thereof
CN100579564C (en) Medicine for curing gout and its preparing method
CN105055967B (en) A kind of complex health care product and preparation method with auxiliary hyperglycemic function
CN103933154B (en) A kind of Chinese medicine composition treating goat and preparation method thereof
CN110624067B (en) Traditional Chinese medicine composition with weight-losing effect and preparation method of ointment thereof
CN103272146B (en) Medicine composition used for preventing and treating alcoholic fatty liver and preparation method thereof
CN102302655B (en) Loquat acne removing capsules
JP5265347B2 (en) Use of konjac and its extract in formulating pharmaceuticals for the treatment of acute and chronic bronchitis
CN100486621C (en) Chinese medicinal composition for treating hemilateral headache and its preparation method
CN102579601A (en) Medicinal composition for treating rheumatoid arthritis, and preparation method and application thereof
CN102293816B (en) Production method of rheumatism dripping pill
CN102526335B (en) Externally applied traditional Chinese medicine for treating gout

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07845659

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07845659

Country of ref document: EP

Kind code of ref document: A1